Viewing Study NCT00002268


Ignite Creation Date: 2025-12-24 @ 5:55 PM
Ignite Modification Date: 2026-01-02 @ 8:57 AM
Study NCT ID: NCT00002268
Status: COMPLETED
Last Update Posted: 2005-06-24
First Post: 1999-11-02
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Randomized, Phase I/II Trial to Assess the Safety and Antiviral Effects of Escalating Doses of A Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV Viremia and/or Viruria
Sponsor: Sandoz
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module